Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint ...

Breast cancer is the most common cancer among women in several countries around the world, including Japan, where 1 in 9 ...

Pulsed field ablation (PFA) technology made some advances with 12-month results for the Globe Pulsed Field System in ...

Several ASX-listed medtech companies are delivering technologies that enhance clinical precision, safety, and efficiency in healthcare.

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

"Despite the catheter being large ... there are not many vascular complications ... not any major transseptal-related or left atrial perforation-related stuff." "Future adoption of the technology ...

For medically refractory vasovagal syncope (VVS) and functional bradycardia, the feasibility of off-label catheter ...

An electrocardiograph with continuous telemetry showed new-onset paroxysmal atrial flutter without ST-segment ... despite multiple rounds of standard advanced cardiac life support and infusion ...

Pulsed field ablation dominated discussions and scientific sessions at Heart Rhythm 2025 in San Diego with researchers and ...

Deep sedation with remimazolam plus ketamine during atrial fibrillation ablation is linked to fewer clinically relevant ...